ITRI has been the topic of a number of other research reports. Oppenheimer increased their price objective on shares of Itron from $75.00 to $90.00 in a report on Tuesday, November 5th. Canaccord Genuity boosted their target price on shares of Itron from $77.00 to $87.00 and gave the stock a buy rating in a research note on Monday, October 21st. TheStreet upgraded shares of Itron from a c+ rating to a b- rating in a research report on Friday, August 16th. Stephens set a $83.00 price target on shares of Itron and gave the company a hold rating in a research note on Friday, October 18th. Finally, Robert W. Baird increased their price target on shares of Itron from $80.00 to $86.00 and gave the company an outperform rating in a research note on Tuesday, November 5th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $77.90.
Shares of ITRI stock traded up $0.21 during trading hours on Friday, hitting $84.47. 168,585 shares of the company’s stock were exchanged, compared to its average volume of 224,087. The stock’s 50-day moving average is $78.96 and its 200-day moving average is $69.63. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.41 and a quick ratio of 1.07. The stock has a market cap of $3.28 billion, a price-to-earnings ratio of 31.88, a price-to-earnings-growth ratio of 1.05 and a beta of 1.09. Itron has a 52 week low of $44.35 and a 52 week high of $84.85.
Itron (NASDAQ:ITRI) last announced its earnings results on Monday, November 4th. The scientific and technical instruments company reported $1.04 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.38. Itron had a return on equity of 18.69% and a net margin of 2.37%. The company had revenue of $624.47 million during the quarter, compared to analyst estimates of $622.63 million. During the same period last year, the company posted $1.13 earnings per share. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. Equities research analysts forecast that Itron will post 3.14 earnings per share for the current fiscal year.
In other Itron news, Director Thomas S. Glanville sold 1,000 shares of the business’s stock in a transaction dated Friday, October 11th. The stock was sold at an average price of $75.10, for a total transaction of $75,100.00. Following the completion of the sale, the director now directly owns 11,056 shares of the company’s stock, valued at approximately $830,305.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Lynda L. Ziegler sold 3,369 shares of the business’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $73.48, for a total value of $247,554.12. Following the sale, the insider now directly owns 11,238 shares of the company’s stock, valued at $825,768.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,789 shares of company stock worth $2,684,594. 2.35% of the stock is owned by company insiders.
Large investors have recently made changes to their positions in the business. BlackRock Inc. raised its holdings in Itron by 1.2% during the 2nd quarter. BlackRock Inc. now owns 4,987,689 shares of the scientific and technical instruments company’s stock worth $312,079,000 after purchasing an additional 60,154 shares during the last quarter. Stifel Financial Corp bought a new stake in Itron during the 3rd quarter worth about $8,468,000. Bogle Investment Management L P DE bought a new stake in Itron during the 2nd quarter worth about $587,000. Louisiana State Employees Retirement System raised its holdings in Itron by 4.0% during the 3rd quarter. Louisiana State Employees Retirement System now owns 13,000 shares of the scientific and technical instruments company’s stock worth $961,000 after purchasing an additional 500 shares during the last quarter. Finally, Putnam FL Investment Management Co. raised its holdings in Itron by 9.9% during the 3rd quarter. Putnam FL Investment Management Co. now owns 10,905 shares of the scientific and technical instruments company’s stock worth $807,000 after purchasing an additional 983 shares during the last quarter. 95.19% of the stock is owned by hedge funds and other institutional investors.
Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
Recommended Story: What are the advantages to having securities held in street name?
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.